Showing results (171-180 of 346) with videos related to

Sort By:
Pageof 35
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2011
Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndromeGheath Alatrash, Matteo Pelosini, Rima M Saliba, et al.
Vaccines|September 28, 2024
Humoral Immunity and Antibody Responses against Diphtheria, Tetanus, and Pneumococcus after Immune Effector Cell Therapies: A Prospective StudyGeorgios Angelidakis, Roy F Chemaly, Pranoti V Sahasrabhojane, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2018
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid LeukemiaMithun Vinod Shah, Jeffrey L Jorgensen, Rima M Saliba, et al.
The Lancet. Haematology|July 9, 2017
Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE studyHagop M Kantarjian, Daniel J DeAngelo, Anjali S Advani, et al.
Blood|August 6, 2009
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host diseaseSimrit Parmar, Marcos Del Lima, Yizhou Zou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2017
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil RecoveryRohtesh S Mehta, Rima M Saliba, Kai Cao, et al.
Blood|April 24, 2013
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantationAnn M Leen, Catherine M Bollard, Adam M Mendizabal, et al.
British Journal of Haematology|March 16, 2017
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survivalPhilip A Thompson, Francesco Stingo, Michael J Keating, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2011
Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of lifeGheath Alatrash, Marcos de Lima, Nelson Hamerschlak, et al.
Blood|April 27, 2012
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCRHiroki Torikai, Andreas Reik, Pei-Qi Liu, et al.
Pageof 35